JAMA Surg:意外发现胆囊癌,首次胆囊切除术到再次手术的更佳时间间隔是4到8周

2016-10-27 MedSci MedSci原创

目前的建议是,对偶然发现的胆囊癌患者进行再手术切除术。关于患者选择和长期生存的最佳再切除时间间隔是不知道的。评估最初胆囊切除术到再次手术的时间间隔,与总生存期的相关性。这项队列研究是从2000年1月1日到2014年12月31日在美国10个学术机构进行。总共有207例偶然发现的胆囊癌患者进行了再手术。最初胆囊切除术到再次手术的时间间隔分为:A组,不到4周;B组,4至8周;C组,大于8周。主要结果为总

目前的建议是,对偶然发现的胆囊癌患者进行再手术切除术。关于患者选择和长期生存的最佳再切除时间间隔是不知道的。评估首次胆囊切除术到再次手术的时间间隔,与总生存期的相关性。这项队列研究是从2000年1月1日到2014年12月31日在美国10个学术机构进行。总共有207例偶然发现的胆囊癌患者进行了再手术。首次胆囊切除术到再次手术的时间间隔分为:A组,不到4周;B组,4至8周;C组,大于8周。主要结果为总生存期。449例胆囊癌患者,207例(46%)是偶然发现,并接受手术,根据首次胆囊切除术到再次手术的时间间隔分为分组:A组,不到4周(25例, 12%);B组,4至8周(91例, 44%);C组,大于8周(91例, 44%)。A组、B组和C组的平均年龄分别为65(9)、64(11)和66(12)岁。基线人口统计、切除范围、残余疾病的存在、T分期、淋巴结受累、等在各组均相似。B组患者的中位总生存期最长(40.4个月),A组为17.4个月,C组为22.4个月(log-rank P = .03)。在单变量Cox回归分析中,与B组比较,A组和C组的时间间隔、残余疾病存在、R2切除、T分期、淋巴结受累等

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1678990, encodeId=2b5d16e899067, content=<a href='/topic/show?id=df0a834328b' target=_blank style='color:#2F92EE;'>#胆囊切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83432, encryptionId=df0a834328b, topicName=胆囊切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4d227724361, createdName=huangshifeng, createdTime=Sat Mar 25 11:27:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876841, encodeId=09e418e68415d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 24 14:27:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315178, encodeId=e01a13151e8dc, content=<a href='/topic/show?id=11788344565' target=_blank style='color:#2F92EE;'>#胆囊癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83445, encryptionId=11788344565, topicName=胆囊癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429784, encodeId=a8e31429e8400, content=<a href='/topic/show?id=140783434c7' target=_blank style='color:#2F92EE;'>#胆囊切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83434, encryptionId=140783434c7, topicName=胆囊切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f94230600, createdName=yangfl07, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1678990, encodeId=2b5d16e899067, content=<a href='/topic/show?id=df0a834328b' target=_blank style='color:#2F92EE;'>#胆囊切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83432, encryptionId=df0a834328b, topicName=胆囊切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4d227724361, createdName=huangshifeng, createdTime=Sat Mar 25 11:27:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876841, encodeId=09e418e68415d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 24 14:27:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315178, encodeId=e01a13151e8dc, content=<a href='/topic/show?id=11788344565' target=_blank style='color:#2F92EE;'>#胆囊癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83445, encryptionId=11788344565, topicName=胆囊癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429784, encodeId=a8e31429e8400, content=<a href='/topic/show?id=140783434c7' target=_blank style='color:#2F92EE;'>#胆囊切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83434, encryptionId=140783434c7, topicName=胆囊切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f94230600, createdName=yangfl07, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1678990, encodeId=2b5d16e899067, content=<a href='/topic/show?id=df0a834328b' target=_blank style='color:#2F92EE;'>#胆囊切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83432, encryptionId=df0a834328b, topicName=胆囊切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4d227724361, createdName=huangshifeng, createdTime=Sat Mar 25 11:27:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876841, encodeId=09e418e68415d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 24 14:27:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315178, encodeId=e01a13151e8dc, content=<a href='/topic/show?id=11788344565' target=_blank style='color:#2F92EE;'>#胆囊癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83445, encryptionId=11788344565, topicName=胆囊癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429784, encodeId=a8e31429e8400, content=<a href='/topic/show?id=140783434c7' target=_blank style='color:#2F92EE;'>#胆囊切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83434, encryptionId=140783434c7, topicName=胆囊切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f94230600, createdName=yangfl07, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1678990, encodeId=2b5d16e899067, content=<a href='/topic/show?id=df0a834328b' target=_blank style='color:#2F92EE;'>#胆囊切除#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83432, encryptionId=df0a834328b, topicName=胆囊切除)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4d227724361, createdName=huangshifeng, createdTime=Sat Mar 25 11:27:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1876841, encodeId=09e418e68415d, content=<a href='/topic/show?id=67c5319121e' target=_blank style='color:#2F92EE;'>#切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31912, encryptionId=67c5319121e, topicName=切除术)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9d8a96, createdName=doctorzheng, createdTime=Sun Sep 24 14:27:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315178, encodeId=e01a13151e8dc, content=<a href='/topic/show?id=11788344565' target=_blank style='color:#2F92EE;'>#胆囊癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83445, encryptionId=11788344565, topicName=胆囊癌)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62e4433, createdName=zz12341234, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429784, encodeId=a8e31429e8400, content=<a href='/topic/show?id=140783434c7' target=_blank style='color:#2F92EE;'>#胆囊切除术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83434, encryptionId=140783434c7, topicName=胆囊切除术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3f94230600, createdName=yangfl07, createdTime=Sat Oct 29 07:27:00 CST 2016, time=2016-10-29, status=1, ipAttribution=)]

相关资讯

J Natl Cancer Inst:含糖饮料摄入过多可增加胆囊癌的发生风险

研究已经表明摄入含糖饮料可升高血糖浓度,且与体重增加和2型糖尿病的发生密切相关,而这些都与胆道癌(BTC)的发生相关。本研究假设含糖饮料的消费量与BTC的发生风险成正相关。研究共70832名瑞典成人(55.9%为男性,年龄45-83年),均未患有癌症和糖尿病,基线时期完成了食物频率调查问卷。通过瑞典癌症登记册确定BTC病例。使用Cox比例风险回归模型来分析数据。在平均13.4年的随访期间,共有12

Nat Genet:胆囊癌关键基因ErbB被发现

7月6日,国际学术期刊《自然—遗传学》(Nature Genetics)杂志在线发表了营养所王慧研究组与上海交通大学附属新华医院刘颖斌教授、复旦大学生物医学研究院刘赟副教授等实验室合作的研究成果: Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in t

解读胆道肿瘤TNM分期变化,规范胆道肿瘤外科治疗

       作者:李斌 张柏和  刘辰  罗祥基  易滨  善小涪        自1992年由美国癌症联合委员会(AJCC)和国际抗癌联盟(UICC)共同推出第4版TNM肿瘤分期开始,TNM分期就成为目前国际通用的决定癌症病期、选择治疗方案、判断预后、比较疗效的&l